The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic’s CoreValve Transcatheter for use without undergoing an independent device advisory panel review for the product, ...
Patients implanted with the CoreValve transcatheter aortic valve replacement showed strong blood flow and improved quality of life at five years post-implant, according to results from two Medtronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results